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THE ECONOMIC BURDEN OF ADULT OBESITY,WITH
SPECIAL REFERENCE TO DRUG CONSUMPTION: ESTIMATES
FROM THE KORA STUDY REGION
John J1, Hartmann J1,Von Lengerke T2
1GSF—National Center for Environment and Health, Neuherberg,
Bavaria, Germany; 2Hannover Medical School, Hannover,
Niedersachsen, Germany
OBJECTIVES: To analyze the association between costs of
illness and degree of obesity for a population-based sample of
German adults. METHODS: In a cross-sectional resident popu-
lation survey in the KORA study region of Augsburg, Germany
(random sampling, N = 947, age: 25–74 years), body mass index
(BMI) was assessed anthropometrically and categorized into
normal weight (18.5 £ BMI < 25), preobese (25 £ BMI < 30),
obese class 1 (30 £ BMI < 35) and obese classes 2–3 (BMI ≥ 35).
Health care utilization and inability to work were assessed by
self-reports via three computer-aided telephone interviews over
six months. For drugs, actual prices were used; for all other
direct cost components, costs were calculated by imputing mean
unit costs on the reported resource consumption ﬁgures. Indirect
costs (productivity loss due to temporary inability to work) were
valued by individual gross earnings. Multivariate regression
models were used to estimate the effect of BMI on direct and
indirect costs of illness, while controlling for age, sex, social
status, and urban vs. rural place of residence. RESULTS: Com-
pared with persons of normal weight, obesity class 1 (obesity
classes 2–3) was associated with 39% (63%) higher costs of
visits to general practitioners, 51% (388%) higher costs of inpa-
tient hospital care, and 19% (136%) higher costs of drug uti-
lization. Higher drug expenditures for male obese adults were
particularly due to diseases of the alimentary tract and metabo-
lism and diseasesof the musculoskeletal system, and for female
obese adults due to diseases of the cardiovascular system. Alto-
gether, yearly per capita costs of illness (direct plus indirect) in
these 3 groups added up to €2116€ (95% CI €1427–€2805),
€2643 (95% CI €1848–€3438), and €5453 (95% CI
€4102–€6803). CONCLUSIONS: Results point to a consider-
able economic impact of obesity, especially obesity classes 2–3.
The lesson for health care research is that obesity class 1 and
obesity classes 2–3 should be analyzed separately.
POB4
COST-OF-ILLNESS ANALYSIS OF JUVENILE OBESITY AND OF
CO-MORBIDITY TYPE 2 DIABETES MELLITUS (T2DM) IN
GERMANY
Wolfenstetter SB
GSF—National Research Center for Environment and Health,
Neuherberg, Bavaria, Germany
OBJECTIVES: Obesity among children has developed into a
major public health problem in Germany. In 1999 15% of chil-
dren aged 14–17 years were obese and approximately 1% of
these were diabetics. Obesity and T2DM are important causes
of morbidity among young people associated with high costs for
the health system. The objective of this paper is to estimate the
economic burden of illness of obesity and T2DM of children and
adolescents in Germany. METHODS: Cost calculations are
based on the top down approach and the prevalence method.
Direct costs of illness are derived from aggregate statistical data
and various scientiﬁc publications. Included are costs of hospi-
talization (ICD 10: obesity E 65–67; T2DM E 11), costs of reha-
bilitation and costs of special medical programs for obese
children. Other direct costs (as e.g. costs of remedies and aids or
costs of drugs) could not be included due to a lack of data; 
the same holds for indirect costs. Except for T2DM, co-mor-
bidities of obesity are neglected in this analysis. RESULTS:
During 1999–2003 the mean direct costs of obesity per year were
€58.3 million with €51.8 million for rehabilitation, €3.2 million
for hospital care and €3.3 million for special medical programs.
The costs of juvenile T2DM were €0.7 million (hospital care).
Mean costs per treated obese child added up to €3540 and to
€5720 per treated obese child with T2DM. CONCLUSION:
Obesity and T2DM are rapidly emerging as major disorders of
childhood and adolescence and as important cost drivers for the
health system. There is a need for further research in costs of
obesity and T2DM of children and for studies on intervention
to obviate a major public health crisis in Germany. The challenge
for health policy is to identify effective and efﬁcient prevention
strategies.
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AN ANALYSIS OF THE IMPACT OF BARIATRIC SURGERY ON
HEALTH OUTCOMES AND PHARMACOLOGICAL TREATMENT
AMONG OBESE PATIENTS
Ledoux S1, Clerici C1, Moyneur É2, Salomon L1, Cremieux F1,
Ouellette P3, Cremieux PY2
1Hôpital Louis Mourier, Colombes, France; 2Analysis Group Inc,
Boston, MA, USA; 3Universite du Quebec a Montreal, Montreal,
Quebec, Canada
OBJECTIVE: To identify the impact of bariatric surgery on health
outcomes and pharmacological treatment among obese patients.
METHODS: A comprehensive analysis of 833 patients with a
diagnostic of obesity (ICD-9-CM = 278) with a CPT code of
bariatric surgery (43,659, 43,842, 43,843, 43,846, 43,847,
43,999, S2085) was performed. The sample was drawn from a
US administrative claims database covering 2.2 million lives.
Diagnostics and pharmacological treatment were compared in the
180 days preceding the surgery and days 30–210 following the
surgery. Frequency counts were performed on diagnostics using
aggregated 3 digit ICD-9-CM codes and pharmacological treat-
ment using AHFS (American Hospital Formulary Service) thera-
peutic classes. Pre- and post surgery frequencies were compared
using chi-squared tests. RESULTS: Among the 833 patients (mean
age = 42.3, 15.1% male), cardiovascular disease was cut by half
(from 47.5% to 23.9%), diabetes mellitus was reduced from
18.0% to 12.9%, and respiratory disease in general was reduced
from 57.7% to 14.8% while asthma in particular dropped from
11.2% to 3.7%. Diseases of the joints and muscles were reduced
from 36.6% to 24.0%. Psychiatric disorders fell from 18.4% to
9.7%. On the contrary, anemia diagnoses increased from 4.1%
to 13.6%. The frequency of pharmacological treatment for the
conditions identiﬁed above fell dramatically often to a greater
extent than the reduction in the prevalence of the underlying con-
dition. The percentage of patients receiving insulin treatment and
oral antidiabetics decreased from 5.2% to 2.2% and from 12.7%
to 4.3%, respectively. The proportion of patients receiving treat-
ment for cardiovascular diseases (Ace inhibitors, calcium channel
blockers, diuretics, betablockers, and other hypotensives) fell
from 39.3% to 26.1%. Antiacid use also dropped from 26.8%
to 22.2%. All differences between pre- and post surgery propor-
tions are statistically signiﬁcant (P = 0.05). CONCLUSION:
Bariatric surgery is associated with signiﬁcant improvements in
health outcomes and reduced pharmacological utilization for
major disease categories.
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OBJECTIVES: 1. Dietary behavioural in an overweight and
obesity population in treatment, 2. Physical activity, 3. To eval-
uate if the group that reaches the minimum objective (weight loss
> 5%), has got more life style changes. METHODS: Randomised
controlled trial, 165-subjects: 70 control, 95 intervention.
Weight-reduced intervention, one year follow-up: low-calorie
diet, physical exercise promotion, behavioural modiﬁcation tech-
niques and health education. Variables: Sociodemography, nutri-
tion behaviour, physical activity, anthropometry (weight-loss
percentage, body mass index). Intention to treat analysis:
ANOVA, ji2; SPSS 11.0. RESULTS: Age 47.1 (SD12.1). In total,
82.4% Women, 53.9% very unsatisﬁed with the body image,
24.8% has never tried a weight-loss programme, 13.3% has tried
anoretic drugs. Meal Patterns: 93.3% eats at home, 65.9% in
family, 76.4% cooks herself, 65.2% eats only 2-times/day,
61.9% snacks and 54% eats binge, secret or night. Medium
meal-time: 20.1min (SD8.45). Their favourite foods: 37.6%
sweets, 21.8% animal fats, 11.5% bread or ﬂour foods, 5.5%
fruit and vegetables. Smoking 25.5%, drinks no alcohol 71.8%,
no exercise 61.2%. Homogeneity between control-intervention
groups: without signiﬁcant differences in age, sex, socioeconomic
characteristics and lifestyle behaviour. There are no differences
in weight measurements. Seventy-two subjects are lost (43.6%).
No signiﬁcant differences between the lost group and these who
complete the therapy in age, sex, previous pathology, habits or
weight. In the group that reaches the minimum objective, there
is declining of snacking, less appetence of bingeing, secret or
night eating, increasing of the daily meals and more time needed
in every meal (<0.05). Increasing physical exercise during and
post-treatment are associated with weight loss >5% (p < 0.05).
Higher intensity grade of physical activity during the diet is
related with leaving obesity (p = 0.00) and returning normal
weight (p < 0.001). People with successful outcome, experiment
increasing satisfaction with the body image (p = 0.00). CON-
CLUSIONS: 1. Nutrition behaviour in overweight and obese
patients are far away of the healthy lifestyle recommendations.
2. 61.2% no exercise. 3. The improvement in life style habits
produces a signiﬁcant weight loss >5%.
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COSTS AND HEALTH CARE CONSUMPTIONS IN THE
ABDOMINALLY OBESE POPULATION
Radigue C1,Wolf AM2,Allshouse AA3, Coste F1, Maneval F1
1Sanoﬁ-Synthelabo Research, Bagneux, Hauts-de-Seine, France;
2University of Virginia, Charlottesville,VA, USA; 3RTI Health Solutions,
Raleigh, NC, USA
OBJECTIVES: Prospective Obesity Cohort of Economic Evalu-
ation Determinants (PROCEED) is an ongoing longitudinal
cohort of overweight subjects aged 35–75 intending to lose
weight. The primary objective is to compare health care con-
sumptions and costs in subjects who are overweight (BMI 25
kg/m2) with or without abdominal obesity (AO) (waist circum-
ference 102cm for male and 88cm for female) versus non-over-
weight subjects (BMI 20–24kg/m2). METHODS: Recruitment
started in the US in November 2004. Internet-based follow-up
assessments will occur monthly for weight and waist circumfer-
ence of overweight subjects, and quarterly for health and eco-
nomic outcomes (hospitalizations, ER, outpatient services,
prescription medications for selected conditions) of all subjects.
RESULTS: Baseline analysis was conducted on non-overweight
subjects (100) and overweight subjects with waist circumference
measurement (293 without AO and 674 with AO). Health care
resource costs per participant were calculated by applying unit
costs to health care resource consumption reported at baseline
during the past 3 months. Mean costs in overweight subjects
with AO were almost twice those in overweight subjects without
AO ($132 versus $72), and over 3.5 times those of controls
($37). Overweight subjects with AO compared with those
without AO were more likely to have reported current prescrip-
tions for depression (21.1% versus 12.3%) and diabetes (11.9%
versus 4.4%). The percentage of subjects with zero costs was
23% and 31% in the overweight group (AO and non AO,
respectively) compared with 39% in the control group. CON-
CLUSION: Abdominal obesity appears to be associated with
markedly increase costs, especially those related to prescriptions.
As the PROCEED cohort progresses, further collection and
analyses of economic outcomes will allow a deeper understand-
ing of the impact of abdominal obesity on costs and health care
consumptions.
POB8
VALIDITY OF DATA COLLECTED FROM AN INTERNET-BASED
COHORT STUDY
Coste F1, Zhou X2, Radigue C1, Maneval F1
1Sanoﬁ-Synthelabo Research, Bagneux, Hauts-de-Seine, France; 2RTI
Health Solutions, Raleigh, NC, USA
OBJECTIVES: Assessment Towards Tobacco Economical and
Medical Prospective Trial (ATTEMPT) is a prospective multina-
tional observational longitudinal cohort designed to examine the
natural course of successive smoking cessation attempts and their
impact on health and economic outcomes. In order to evaluate
the validity of the data collected via the Internet, self-reported
weight and waist circumference (WC) were compared to in-home
assessed measurements. METHODS: Subjects were recruited
from existing Internet consumer panels Harris Interactive in 5
countries: Canada, France, Spain, the UK and the US. Subjects
had to be aged 35–65 years, smoke at least 5 cigarettes per day,
and intend to quit smoking. Assessments included questions 
on smoking status, health conditions, medical resource use and
quality of life. Study participants were mailed at home stan-
dardized weight scales and tape measures with instructions. In-
home assessments were performed by a health professional in a
random sample of the US subjects right after they completed the
quarterly Internet survey. RESULTS: Out of the 4647 subjects
included at baseline, 3242 (70%) completed the 3-month assess-
ments and 2917 (63%) completed the 6-month assessments. In
the US, 1147 (78%) subjects agreed to the in-home visit and 200
visits were conducted according to protocol speciﬁcations in
December 2004 and January 2005. No statistically signiﬁcant
difference and high positive correlations were found between
self-reported and observed weight (mean ± SD difference: under-
self-reported +0.6 ± 6.3kg; correlation: 0.95) and waist cir-
cumference (over-self-reported -0.3 ± 10.3cm; 0.81). The
distribution of demographic characteristics for the assessed
sample was similar to characteristics of the remaining cohort.
CONCLUSIONS: Based on good correlations between in-home
visit and self-reporting on the web in the US, Internet is a reli-
able tool to collect health related data. As the ATTEMPT cohort
progresses, this analysis will be reassessed with a greater sample
size and further explored in other countries.
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UTILITY (EQ5D)
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OBJECTIVE: A higher Body Mass Index (BMI) is associated
with decreased quality of life (QoL). Additional athropometric
